Abstract
Introduction: Within the first year of the SARS-CoV-2 pandemic, Brazil was second only to the USA in number of cases. An important change was observed in the profile of patients, notably oncology patients, with an estimated diagnostic deficit of at least 15,000 new cases of cancer per month across the country in 2020 (a drop of 35.5%).
Objective: Investigate the impact of the SARS-CoV-2 pandemic on the quantity and profile of surgical diagnoses between April 2018 and March 2022.
Results: There was a 22.8% decrease in surgical diagnoses during the Pandemic and a 39.0% lower monthly average, being the Gynecological diagnoses the most affected (-69.4%) Conclusion: A significant diagnostic deficit was created and changes in the diagnostic profile were observed.
Publisher
Athenaeum Scientific Publishers
Reference13 articles.
1. Santos CVB, Cavalcante JR, Pungartnik PC, Guimarães RM. Análise espaço temporal do primeiro ano da pandemia de COVID-19 no município do Rio de Janeiro. Rev Bras Epidemiol. 2021;24:e210046
2. Neiva MB, Carvalho I, Costa Filho E dos S, Barbosa-Junior F, Bernardi FA, Sanches TLM, et al. Brazil: the emerging epicenter of COVID-19 pandemic. Rev Soc Bras Med Trop. 2020;53:e20200550.
3. Werneck GL, Porto LC, Sena A, Ferreira Junior O da C, Cavalcanti AC, Santos ÂMG, et al. The incidence and geographical spread of SARS-CoV-2 in Rio de Janeiro, Brazil based on RT-PCR test results. Rev Soc Bras Med Trop. 2021;54:e07792020.
4. Gomes WJ, Rocco I, Pimentel WS, Pinheiro AHB, Souza PMS, Costa LAA, et al. COVID-19 in the Perioperative Period of Cardiovascular Surgery: the Brazilian Experience. Braz J Cardiovasc Surg. 2021;36(6).
5. Mahl C, Melo LRS de, Almeida MHA, Carvalho CS, Santos LLS, Nunes PS, et al. Delay in head and neck cancer care during the COVID-19 pandemic and its impact on health outcomes. Braz Oral Res. 2020;34:e126.